Application of niclosamide and analogs as small molecule inhibitors of Zika virus and SARS-CoV-2 infection

Zika virus has emerged as a potential threat to human health globally. A previous drug repurposing screen identified the approved anthelminthic drug niclosamide as a small molecule inhibitor of Zika virus infection. However, as antihelminthic drugs are generally designed to have low absorption when...

Descripción completa

Detalles Bibliográficos
Autores principales: Shamim, Khalida, Xu, Miao, Hu, Xin, Lee, Emily M, Lu, Xiao, Huang, Ruili, Shah, Pranav, Xu, Xin, Chen, Catherine Z., Shen, Min, Guo, Hui, Chen, Lu, Itkin, Zina, Eastman, Richard T., Shinn, Paul, Klumpp-Thomas, Carleen, Michael, Sam, Simeonov, Anton, Lo, Donald C., Ming, Guo-li, Song, Hongjun, Tang, Hengli, Zheng, Wei, Huang, Wenwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science Ltd 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936759/
https://www.ncbi.nlm.nih.gov/pubmed/33689873
http://dx.doi.org/10.1016/j.bmcl.2021.127906

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936759/
https://www.ncbi.nlm.nih.gov/pubmed/33689873
http://dx.doi.org/10.1016/j.bmcl.2021.127906

Ejemplares similares